Cargando…
1633P Why do cancer clinical trials (CT) discontinue prematurely in the era of COVID-19?
Autores principales: | Iannantuono, G.M., Torino, F., Strigari, L., Capotondi, B., Dell'Aria, F., Flaminio, V., Guerriero, S., Parisi, G., Rosenfeld, R., Amodio, F., Creso, B., Filomeno, L., Mastrobattista, F., Meacci, A., Palumbo, F.E., Santurri, L., Sganga, S., Roselli, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454356/ http://dx.doi.org/10.1016/j.annonc.2021.08.1626 |
Ejemplares similares
-
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer
por: Iannantuono, Giovanni Maria, et al.
Publicado: (2022) -
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series
por: Iannantuono, Giovanni Maria, et al.
Publicado: (2022) -
Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives
por: Sganga, Stefano, et al.
Publicado: (2023) -
Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review
por: Iannantuono, Giovanni Maria, et al.
Publicado: (2022) -
Padua, the cradle of modern medicine: Bernardino Ramazzini (1633–1714) on headaches
por: Zanchin, G.
Publicado: (2005)